Financials data is unavailable for this security.
View more
Year on year Zhejiang Hisun Biomaterials Co Ltd had net income fall -7.41% from 47.04m to 43.55m despite a 24.43% increase in revenues from 605.43m to 753.32m. An increase in the cost of goods sold as a percentage of sales from 86.64% to 86.91% was a component in the falling net income despite rising revenues.
| Gross margin | 11.91% |
|---|---|
| Net profit margin | 4.61% |
| Operating margin | 5.98% |
| Return on assets | 1.99% |
|---|---|
| Return on equity | 2.67% |
| Return on investment | 2.46% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Zhejiang Hisun Biomaterials Co Ltd fell by 87.15m. However, the company earned 163.03m from its operations for a Cash Flow Margin of 21.64%. In addition the company used 213.80m on investing activities and also paid 38.16m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 7.39 |
|---|---|
| Tangible book value per share | 7.01 |
More ▼
Balance sheet in CNYView more
| Current ratio | 2.01 |
|---|---|
| Quick ratio | 1.58 |
| Total debt/total equity | 0.2126 |
|---|---|
| Total debt/total capital | 0.1753 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share increased 14.29% while earnings per share excluding extraordinary items fell by -23.26%. The positive trend in dividend payments is noteworthy since only some companies in the Chemical Manufacturing industry pay a dividend.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 40.82% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -21.99 |
More ▼
